International Journal of Antimicrobial Agents

Papers
(The H4-Index of International Journal of Antimicrobial Agents is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Title Page & Editorial Board85
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page71
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems70
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms60
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen59
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page57
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr53
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis53
Title Page & Editorial Board52
Characterisation of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol51
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings50
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page46
Heterogeneous Vancomycin Intermediate Staphylococcus aureus infections in tertiary care hospitals in Coastal Karnataka, India45
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page45
Mycobacterium species on the cutaneous microbiome of very preterm neonates admitted to the NICU in a tertiary health care hospital43
Emergence of intrinsically resistant Gram-negative bacteria with an environmental primary habitat41
Antimicrobial therapy for carbapenem-resistant gram-negative bacteria40
Vaccines against SARS-COV-240
In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae39
Severe Salmonella enteritidis infection complicated with colonic perforations and abdominal cocoon38
Hospitalization decision model for COVID-19 patients with comorbidities37
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page36
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page34
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota34
Large-scale comparative analysis reveals phylogenomic preference of blaNDM-1 and blaKPC-2 transmission among Klebsiella pneumoniae33
Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen33
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis32
Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria32
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho32
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis31
Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans31
0.095822095870972